EAN News Network

Dr DeLuca provides an overview of changes in cognition and brain volume loss in patients with multiple sclerosis.

Multiple sclerosis expert, Dr DeLuca, shares study design and clinical data on the association between brain volume and long-term cognition in patients with relapsing MS.

Dr DeLuca shares his advice and recommendations from National MS Society on providing cognitive care for patients suffering from MS.

A multiple sclerosis expert, Dr Gabrielle Macaron, discusses factors that can lead to a change of therapy for patients with multiple sclerosis.

Dr Gabrielle Macaron reviews data with ozanimod in treatment naïve vs experienced patients with relapsing multiple sclerosis presented at EAN 2022.

Dr Macaron shares her interpretation of the data and importance of individualizing treatment for patients with multiple sclerosis.

Dr Wallace Brownlee discusses reasons of and clinical impact of treatment discontinuation in multiple sclerosis.

A multiple sclerosis expert, Dr Brownlee shares study design and clinical data on relapse following discontinuation of ozanimod in patients with multiple sclerosis.

Dr Brownlee shares his advice and recommendations from national MS society on providing cognitive care for patients suffering from MS.

Dr Darin Okuda discusses strategies for treatment selection and management of relapses in multiple sclerosis.

A multiple sclerosis expert, Dr Darin Okuda reviews long-term outcomes with ozanimod in DAYBREAK trial based on the number of relapses that was presented at EAN 2022.

Dr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.